F 0583
Keep residents' personal and medical records private and confidential.
Level of Harm - Minimal harm
or potential for actual harm
On 06/04/24 at 9:11 AM. During medication administration observation was done on nursing unit C with
Staff D, Licensed Practical Nurse, (LPN) using medication cart number one. During the medication
administration observation Staff D, LPN walked away from the medication cart number one and entered a
resident's room, leaving the computer screen open and resident's personal information visible.
Residents Affected - Few
On 06/04/24 at 9:15 AM Staff D, LPN returned to medication cart number one and stated to surveyor, I
made a mistake. I am supposed to close the computer screen whenever I leave the cart. I didn't close the
screen because I forgot.
Based on observation and interview the facility failed to ensure residents' confidential medical records were
secure. As evidenced, two medication carts (Cart #1, Cart #2) on Unit C, were left unattended and the
screen for the Electronic Medication Administration Records (EMAR) was unlocked, displaying residents'
information on the screen. There were 136 residents residing in the facility at the time of survey.
The findings included:
On 06/04/24 at 09:00 AM during observation on Unit C, Medication cart # 2 was left unattended with the
Electronic Medication Administration Records (EMAR) screen unlocked, displaying patient s' information on
the screen. The cart was assigned to Licensed Practical Nurse (Staff A). During this observation, the
Director of Nursing (DON) was present in the hallway and noticed the open EMAR screen on the cart and
placed a sheet of paper over the screen. The DON reported she is not sure if something is wrong with the
screen, because it is not shutting down.
On 06/04/24 at 09:02 AM (Staff A) approached the medication cart and noticed the unlocked screen, Staff
A stated: I am so stressed, it is my first time with the state surveyors. The DON stated to the nurse; you
cannot walk away and leave your computer screen open. The nurse (Staff A) acknowledged DON
instructions. Staff A stated, I know I am not supposed to leave the computer screen open when I am not
with the cart.
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 5
Event ID:
105711
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105711
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/06/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Shoreside Health and Rehabilitation Center
201 NE 112th Street
Miami, FL 33161
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation and interview the facility failed to follow the facility's policy regarding pharmacy procedures. As
evidenced by during medication administration observation on Unit C, Licensed Practical Nurse (Staff A)
administered an incorrect dosage of insulin to Resident #87. There were two residents that receive routine
insulin residing on Unit C.
The findings included:
On 06/04/24 at 9:17 AM during medication administration observation with Licensed Practical Nurse (Staff
A). it was observed that Staff A administered 15 units of Lantus ® (insulin glargine injection) to
Resident# 87's left upper abdomen. Resident # 87 had an order for 16 units of Lantus, 100 Units /ML (units
per milliliter) subcutaneously two times a day for Diabetes Mellitus. The surveyor requested Staff A check
the orders for Resident #87's Lantus, Staff A checked Resident #87's orders and said the order is for 16
units of Lantus and she gave the resident 15 units. In a situation like this I will speak to my supervisor and
see what I need to do, in the meantime I will keep an eye on the resident.
On 06/04/24 at 09:37 AM, the Director of Nursing (DON) told the surveyor that Staff A told her about the
incorrect insulin dose given to Resident #87, the DON reported she instructed the nurse (Staff A) to give
the resident the additional 1 unit of Lantus insulin.
Review of the medical records for Resident #87 revealed the resident was admitted to the facility on [DATE],
readmitted on [DATE]. Clinical diagnoses included but not limited to: Type 2 diabetes mellitus with
hyperglycemia.
Review of the Physician's Orders Sheet for June 2024 revealed Resident #87 had orders that included but
not limited to: Lantus 100 unit/ml-inject 16 unit subcutaneously two times a day for Diabetes Mellitus.
Record review of Resident # 87's Quarterly Minimum Data Set (MDS) dated [DATE], Section C for
Cognitive Patterns documented Brief Interview for mental Status Score is 10, on a 0-15 scale indicating the
resident is moderately impaired cognitively.
Review of the facility policy and procedure titled: Administering Medications revision date April 2019 states:
Medications are administered in a safe and timely manner, and as prescribed.
Policy Interpretation and Implementation
Step 4. Medications are administered in accordance with prescriber orders, including any required
timeframe
Step 6. Medication errors are documented, reported, and reviewed by the QAPI committee to inform
process changes and or the need for additional staff training.
Step 9. The individual administering the medication checks the label to verify the right resident, right
medication, right dosage, right time and right method (route) of administration before giving
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105711
If continuation sheet
Page 2 of 5
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105711
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/06/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Shoreside Health and Rehabilitation Center
201 NE 112th Street
Miami, FL 33161
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
the medications.
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105711
If continuation sheet
Page 3 of 5
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105711
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/06/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Shoreside Health and Rehabilitation Center
201 NE 112th Street
Miami, FL 33161
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0759
Ensure medication error rates are not 5 percent or greater.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview and record review the facility failed to ensure the medication error rate was not five
(5) percent or greater. As evidenced by during medication administration observations an incorrect dose of
insulin was given to Resident #87 and Resident #97 did not receive a prescribed injection for Anemia.
There were 136 residents residing in the facility at the time of survey.
Residents Affected - Few
The findings included:
Resident #87
On 06/04/24 at 9:17 AM during medication administration observation with Licensed Practical Nurse (Staff
A). It was observed that Staff A administered 15 units of Lantus (insulin glargine injection) to Resident# 87's
left upper abdomen. Resident # 87 had an order for 16 units of Lantus, 100 Units /ML (units per milliliter)
subcutaneously two times a day for Diabetes Mellitus. The surveyor requested Staff A check the orders for
Resident #87's Lantus, Staff A checked Resident #87's orders and said the order is for 16 units of Lantus
and she gave the resident 15 units. In a situation like this I will speak to my supervisor and see what I need
to do, in the meantime I will keep an eye on the resident.
On 06/04/24 at 09:37 AM, the Director of Nursing (DON) told the surveyor that Staff A told her about the
incorrect insulin dose given to Resident #87, the DON reported she instructed the nurse (Staff A) to give
the resident the additional 1 unit of Lantus insulin.
Review of the medical records for Resident #87 revealed the resident was admitted to the facility on [DATE],
readmitted on [DATE]. Clinical diagnoses included but not limited to: Type 2 diabetes mellitus with
hyperglycemia.
Review of the Physician's Orders Sheet for June 2024 revealed Resident #87 had orders that included but
not limited to: Lantus 100 unit/ml-inject 16 unit subcutaneously two times a day for Diabetes Mellitus.
Resident #97
During an observation on 6/05/24 at 09:19 AM Staff E, Registered Nurse (RN) weighed Resident #97 and
transferred the resident to the in-house dialysis center. Staff E, RN was stopped by surveyor and asked
who is responsible for administering the RETACRIT injection scheduled to be given that morning to
Resident #97. Staff E, RN responded: I am responsible for administering the injection. I was going to
administer the injection, but time got away from me. I will speak with the doctor now.
Record review of demographic sheet for Resident #97 revealed an admission date of 1/25/24 and re
admission date 1/30/24 with diagnosis that included Anemia.
Review of physician orders for Resident #97 revealed an order dated 5/15/24 for RETACRIT Injection
Solution 4000 UNIT per Milliliter (ml) Inject 4000 ml subcutaneously in the morning, every Monday,
Wednesday, and Friday for Anemia, schedule 8:00 AM.
Record review of most recent laboratory blood work dated 5/22/24 revealed a hemoglobin level of 8.8
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105711
If continuation sheet
Page 4 of 5
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105711
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/06/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Shoreside Health and Rehabilitation Center
201 NE 112th Street
Miami, FL 33161
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0759
(may indicate anemia).
Level of Harm - Minimal harm
or potential for actual harm
On 6/05/24 at 10:25 AM the Director of Nursing (DON) stated: Every Friday we have a Standard of Care
meeting where we discuss dialysis residents and the care needed. This medication should have been given
by 9:00 AM. I informed [Resident #97's] primary care physician (PCP) about the medication omission,
[Resident #97] was assessed by the PCP while in dialysis, and a new order was received to administer the
RETACRIT injection to [Resident #97] at noon today.
Residents Affected - Few
During a follow up observation, Staff E, RN administered the RETACRIT injection at 12:32 PM while
Resident #97 was in dialysis.
Review of the facility policy and procedure titled: Administering Medications revision date April 2019 states:
Medications are administered in a safe and timely manner, and as prescribed.
Policy Interpretation and Implementation
Step 4. Medications are administered in accordance with prescriber orders, including any required
timeframe
Step 6. Medication errors are documented, reported, and reviewed by the QAPI committee to inform
process changes and or the need for additional staff training.
Step 9. The individual administering the medication checks the label to verify the right resident, right
medication, right dosage, right time and right method (route) of administration before giving the
medications.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105711
If continuation sheet
Page 5 of 5